Abstract:Background: This study aimed to investigate whether exogenous hydrogen sulfide (H2S) can protect the RAW264.7 macrophages against the inflammation induced by free fatty acids (FFA) by blunting NLRP3 inflammasome activation via a specific TLR4/NF-κB pathway. Methods: RAW264.7 macrophages were exposed to increasing concentrations of FFA for up to 3 days to induce FFA-induced inflammation. The cells were pretreated with NaHS (a donor of H2S) before exposure to FFA. Cell viability, cell apopt… Show more
“…Original magnifcation, 200 × . [32][33][34]. Here, this study provides the first evidence of exogenous NaHS observably suppressed the expression of NLRP3 inflammasome in PA-induced HepG2 cells.…”
Fatty acids induced hepatic inflammation plays an important role in
nonalcoholic fatty liver disease (NAFLD) pathogenesis. Hydrogen sulfide
(H2S), an endogenous gasotransmitter, has been established to
possess potent anti-inflammation in various human organs. However, the
anti-inflammation property of H2S in the fatty liver is still
needed to further elucidate. Hence, this study aimed to investigate whether
exogenous H2S can protect hepatocytes against inflammation
induced by palmitic acid (PA). HepG2 hepatocytes were exposed to PA for
24 h to induce free fatty acids-induced inflammation. The cells were
pretreated with NaHS (a donor of H2S) before exposure to PA. Cell viability,
inflammatory cytokines (TNF-α, IL-6 and IL-1β), NLRP3
inflammasome and NF-κB were measured by a combination of MTT assay,
ELISA, Western blot and Immunofluorescence. Here, we found that exogenous
H2S dose-dependently inhibited the expression of
pro-inflammatory cytokines, NLRP3 inflammasome and activation of
NF-κB signaling in PA-induced HepG2 cells. Thus, H2S
might be a candidate therapeutic agent against NAFLD.
“…Original magnifcation, 200 × . [32][33][34]. Here, this study provides the first evidence of exogenous NaHS observably suppressed the expression of NLRP3 inflammasome in PA-induced HepG2 cells.…”
Fatty acids induced hepatic inflammation plays an important role in
nonalcoholic fatty liver disease (NAFLD) pathogenesis. Hydrogen sulfide
(H2S), an endogenous gasotransmitter, has been established to
possess potent anti-inflammation in various human organs. However, the
anti-inflammation property of H2S in the fatty liver is still
needed to further elucidate. Hence, this study aimed to investigate whether
exogenous H2S can protect hepatocytes against inflammation
induced by palmitic acid (PA). HepG2 hepatocytes were exposed to PA for
24 h to induce free fatty acids-induced inflammation. The cells were
pretreated with NaHS (a donor of H2S) before exposure to PA. Cell viability,
inflammatory cytokines (TNF-α, IL-6 and IL-1β), NLRP3
inflammasome and NF-κB were measured by a combination of MTT assay,
ELISA, Western blot and Immunofluorescence. Here, we found that exogenous
H2S dose-dependently inhibited the expression of
pro-inflammatory cytokines, NLRP3 inflammasome and activation of
NF-κB signaling in PA-induced HepG2 cells. Thus, H2S
might be a candidate therapeutic agent against NAFLD.
“…H 2 S, previously regarded primarily as an environmental hazard and toxic gas, has recently been recognized as the third gasotransmitter after carbon monoxide (CO) and nitric oxide (NO; Szabo, ). H 2 S has become a focus of researches because of its role in various biological processes, such as neuronal health (Paul & Snyder, ), cardiovascular health, immune response (Yuan, Shen, & Kevil, ), and inflammation (Luo et al, ). Besides, H 2 S has also been reported to regulate cell cycle, proliferation, autophagy, apoptosis, and oxidative stress in malignant tumors (Hellmich & Szabo, ).…”
Diallyl trisulfide (DATS), derived from garlic, is a well‐known hydrogen sulfide (H2S) donor. H2S has recently emerged as a novel gasotransmitter involved in the regulation of cancer progression. The present study demonstrated that DATS along with other two H2S donors, NaHS and GYY4137, significantly inhibited papillary thyroid carcinoma KTC‐1 cells growth. DATS treatment triggered a rapid H2S generation within 5 min in KTC‐1 cells. Iodoacetamide, a potent thiol blocker reagent, partially rescued the cell membrane damage and ultimate cell death induced by DATS, indicating H2S contributed to the apoptosis‐inducing efficacy of DATS on thyroid cancer cells. Specifically, DATS treatment significantly upregulated the expression and enzymatic activity of cystathionine gamma‐lyase (CTH), one of H2S‐producing enzymes, which was responsible for endogenous H2S generation. After DATS treatment, H2S quickly permeated cell membranes and activated NF‐κΒ/p65 signaling pathway in KTC‐1 cells. Nuclear translocated NF‐κB bound to the promoter of CTH to enhance its transcription. These evidences proved that exogenous H2S elevated CTH expression. CTH, in turn, catalytically generated a much higher level of endogenous H2S. This positive feedback sustained excess H2S production, which resulted in PTC cells growth inhibition. These findings may shed light on the development of novel H2S‐based antitumor agents.
“…NF-κB plays a critical role in regulating inflammation and serves as the first signal in the activation of the NLRP3 inflammasome. 12 , 39 – 41 Previous studies demonstrated that NF-κB inhibition led to a remarkable reduction of NLRP3 expression. 33 We found that blocking NF-κB activation with the NF-κB inhibitor BAY-117082 could downregulate NLRP3 expression in BGC-823 cells.…”
Background
Inflammation is considered as one of the hallmarks of cancer development and progression. Ursolic acid (UA) showed strong effects as an anti-inflammatory and antioxidant. However, the anti-cancer effects of ursolic acid require further study.
Methods
This study aimed to investigate the role of ursolic acid in a lipopolysaccharide (LPS)-treated gastric tumour mouse model and in a human gastric carcinoma cell line (BGC-823 cells). This study also aimed to confirm whether ursolic acid can protect against proliferation and the inflammatory response induced by LPS, by inhibiting the activation of the NLRP3 inflammasome via the NF-κB pathway.
Results
The present study demonstrated that ursolic acid significantly attenuated LPS-treated proliferation in a gastric tumour mouse model and the human gastric carcinoma BGC-823 cell line, reduced the expression of the NLRP3 inflammasome and suppressed the release of pro-inflammatory cytokines. In addition, ursolic acid inhibited the LPS-induced activation of NF-κB. Furthermore, the NF-κB pathway regulated the activation of the NLRP3 inflammasome.
Conclusion
In conclusion, these results demonstrated that ursolic acid could suppress proliferation and the inflammatory response in an LPS-induced mouse gastric tumour model and human BGC-823 cells by inhibiting the activation of the NLRP3 inflammasome via the NF-κB pathway. This indicates that ursolic acid can be a potential therapeutic agent for the treatment of gastric cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.